Sernova (TSE:SVA) Reaches New 52-Week Low at $0.28

Shares of Sernova Corp. (TSE:SVA) reached a new 52-week low during trading on Wednesday . The stock traded as low as C$0.28 and last traded at C$0.29, with a volume of 31575 shares trading hands. The stock had previously closed at C$0.28.

Analyst Upgrades and Downgrades

Separately, Raymond James set a C$1.50 price target on shares of Sernova and gave the company a “market perform” rating in a research note on Thursday, April 4th.

Sernova Price Performance

The stock has a market capitalization of C$84.95 million, a price-to-earnings ratio of -2.08 and a beta of 1.53. The company has a quick ratio of 18.11, a current ratio of 1.20 and a debt-to-equity ratio of 16.55. The business’s 50 day simple moving average is C$0.32 and its 200-day simple moving average is C$0.47.

Sernova (TSE:SVA) last posted its quarterly earnings results on Friday, June 14th. The company reported C($0.03) earnings per share for the quarter, meeting analysts’ consensus estimates of C($0.03). On average, research analysts forecast that Sernova Corp. will post -0.08 earnings per share for the current year.

Sernova Company Profile

Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.